Abstract
Candida albicans and Staphylococcus species are, respectively, the most common fungal and bacterial agents isolated from bloodstream infections, worldwide. Moreover, it has been shown that 20% of all C. albicans bloodstream infections are polymicrobial in nature, with Staphylococcus epidermidis and Staphylococcus aureus being the first and third most common co-isolated organisms, respectively. These species are part of the commensal microbial flora but can cause hospital-acquired infections with an extreme ability to inhabit diverse host niches, especially in immunocompromised patients. They are well known for their ability to form persistent biofilms in the host or on abiotic surfaces such as indwelling medical devices. Interactions within these biofilm communities can lead to increased virulence, drug tolerance, and immune evasion. This can ultimately impact morbidity and infection outcome, often leading to an increased mortality. Therefore, characterizing the interactions between these species could lead to the development of novel therapeutic approaches that target polymicrobial infections. In this mini review, we briefly highlight the current knowledge and most recent insights into the complex interspecies interactions of C. albicans with Staphylococcus bacteria.
Highlights
Candida albicans is a commensal fungus that colonizes the oral cavity, vagina, and gastrointestinal tract in most humans (Nobile and Johnson, 2015)
It was shown that degradation of extracellular DNA (eDNA) by DNAse treatment increased the sensitivity of miconazole by two-fold in the mixed C. albicans-S. epidermidis biofilm but not in mono-species biofilms, while extracellular matrix (ECM) chitin and β-1,3-glucan degradation had no such effect (Kean et al, 2017)
Mixed infections of C. albicans with Staphylococcus species are of great importance in clinical settings
Summary
Candida albicans is a commensal fungus that colonizes the oral cavity, vagina, and gastrointestinal tract in most humans (Nobile and Johnson, 2015). Candida albicans/Staphyloccocus Mixed Infections of infections, including those of C. albicans and Staphylococcus species, originate from biofilms and they are often associated with high mortality rates (Tsui et al, 2016). This mini review elaborates on the current knowledge and recent insights in the interactions, altered drug tolerance and infection outcome, and possible treatment strategies of polymicrobial C. albicans-Staphylococcus species infections.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.